Our results, however, show an efficient inhibition of Rad51 foci formation after treatment with wortmannin, which in part explains its higher effect on the clonogenic survival of NSCLC cell lines when compared to a treatment schedule using As-ODN targeting DNA-PKcs (Sak et al, 2002). The gene discussed is PRKDC; the disease is non-small cell lung carcinoma.